
Please try another search
The DeBio Network and KILT Protocol have officially announced their partnership today. As a result, this partnership will enable both networks to share their technologies. To be specific, KILT would integrate its credential into DeBio’s anonymous-first platform for medical and bioinformatics data.
In other words, KILT would serve as the underlying accreditation infrastructure, enabling labs and biomedical facilities to embed credentials on medical test results, genome sequences, and inter-lab collaborations.
On the other hand, DeBio Network, a blockchain-based platform known as Degenics, is creating a decentralized platform. This decentralized platform will provide synergy between medical and bioinformatics organizations while guaranteeing user anonymity and sovereignty throughout the biomedical data pipeline. Indeed, a great technology that really benefits the platform’s users.
Furthermore, to provide an additional layer of security, DeBio Network added a technology that focuses on privacy computing RnD, which maximizes user and data privacy. In fact, the network also aims to partner with Polkado...
This article was first published on coinquora.com
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.